JAZZ PHARMACEUTICALS $69.50

down -1.36


17/6/2013 04:17 PM  |  NASDAQ : JAZZ  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Get Trend Analysis Icon Get JAZZ Trend Analysis - it has outperformed the S&P 500 by 34%

Partner Headlines

  1. Jazz Pharmaceuticals

    Investors Business Daily

  2. Jazz Pharmaceuticals Presents Data from Safety Trial of Patients ...

    Benzinga

  3. Jazz Pharmaceuticals Announces Issuance of Additional Xyrem Patent

    Benzinga

  4. Jazz Pharmaceuticals

    Investors Business Daily

  5. Jazz Pharma Begins Trial of IV Administered Erwinaze

    Benzinga

  6. Stocks Improve Near Midday; Apple, Google Lift Nasdaq

    Investors Business Daily

  7. Jazz Pharma Stock Seesaws After Confusing Q3 Report

    Investors Business Daily

  8. Jazz Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus

  9. Jazz Pharmaceuticals

    Investors Business Daily

  10. Jazz Pharma Earnings Top Estimates As Xyrem Ramps

    Investors Business Daily

  11. Stocks Dive The Most Since June As Fiscal Cliff Looms

    Investors Business Daily

  12. Alkermes' Breakout Falls Victim To Market Correction

    Investors Business Daily

  13. Screen Of The Day: W.R. Grace Tops For Efficiency

    Investors Business Daily

  14. Jazz Pharmaceuticals Completes Sale of its Women's Health Business ...

    Benzinga

  15. W.R. Grace, Jazz Pharma, Seagate Top Daily Screen

    Investors Business Daily

  16. Jazz Pharma Breaks Out From 20-Week Base

    Investors Business Daily

  17. Stocks Rise On U.S. Home Sales, Japan Stimulus

    Investors Business Daily

  18. Wall Street Turns Negative Amid Economic Uncertainty

    Investors Business Daily

  19. Gilead's price target raised

    Investors Business Daily

  20. Stocks Dip In Lower Volume; Aids Drug Boosts Gilead

    Investors Business Daily

  21. Gilead Rises On Price Target, Jazz Gets Positive Ruling

    Investors Business Daily

  22. Jazz Pharmaceuticals Announces Issuance of New Formulation Patent ...

    Benzinga

  23. Jazz Pharmaceuticals Sells Women's Health Business

    Benzinga

  24. A Peek Into The Market Before The Trading Starts

    Benzinga

  25. McDonald's, Polo Ralph Lauren Among Stocks Down on High Volume ...

    FOXBusiness

  26. Jazz Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus

  27. Jazz Pharmaceuticals

    Investors Business Daily

  28. Volume Surges As Stocks Score Third-Straight Win

    Investors Business Daily

  29. Stocks On Track For Third Straight Gain

    Investors Business Daily

  30. Earnings News Drives Early Advance; Fossil Soars

    Investors Business Daily

  31. Pickings Are Slim For U.S.-Listed Foreign Stocks, ADRs

    Investors Business Daily

  32. Can Jazz Pharmaceuticals Lift The Ethical Drug Group?

    Investors Business Daily

  33. UPDATE: Credit Suisse Initiates Jazz Pharmaceuticals with ...

    Benzinga

  34. Jazz Pharma Stock Drops Despite Strong Q1 Showing

    Investors Business Daily

  35. Jazz Pharmaceuticals Down 4.5% on Weak 2012 Guidance

    Benzinga

  36. Jazz Pharmaceuticals

    Investors Business Daily

  37. Jazz Pharma Earnings Top Expectations; Guidance Up

    Investors Business Daily

  38. Jazz Pharmaceuticals (JAZZ) Down 3.6% in Heavy Volume

    At Market Intelligence Center

  39. Jazz Pharmaceuticals

    at IBD

  40. Jazz Pharmaceuticals (JAZZ) Loses 4.5% As Shareholders Plan 7.88 ...

    At Market Intelligence Center

  41. Stocks Take Beating On Worries Over Greece

    at IBD

  42. Stocks Ease Off Lows; Sourcefire Cools Off

    at IBD

  43. Jazz Pharmaceuticals Inc. Reports Operating Results (10-K)

    at GuruFocus

  44. UPDATE: Auriga Raises PT to $57 on JAZZ Pharmaceuticals

    at Benzinga

  45. Jazz Rouses Q4 Profit, Sales

    at IBD

  46. Jazz Earnings Soar As Drug Portfolio Expands

    at IBD

  47. Jazz Pharmaceuticals Adds 2% on Q4 Earnings Results

    at Benzinga

  48. Jazz Pharma Earnings Seen Soaring; Stock Near High

    at IBD

  49. Stocks at New Highs: Jazz Pharmaceuticals Briefly Breaks Above $50

    By SchaeffersResearch

  50. Stocks Stay Mixed; Under Armour Clears 50-Day

    at IBD

  51. Jazz Pharmaceuticals plc Announces New Executive Appointments

    at Benzinga

  52. Stocks Push Off Lows; Jazz Nears Former Buy Point

    at IBD

  53. Stocks Up In Mixed Trade; Texas Instruments Leaps

    at IBD

  54. Comeback Efforts Improve; Stocks On Track For Weekly Gains

    at IBD

  55. Stocks Push Off Lows; Nasdaq Tries For Green

    at IBD

  56. Stocks Tread Water Despite Positive Fed Report

    at IBD

  57. Major Averages Pull Back; Several Leaders Turn Tail

    at IBD

  58. Did John 3:16 Predict These Companies' Successes?

    at Benzinga

  59. Major Averages Rebound Some In Afternoon Trading

    at IBD

  60. Benzinga's Volume Gainers

    at Benzinga

  61. Dollar Weighs Stocks Lower; Jazz Pharmaceuticals Jumps

    at IBD

  62. Jazz Pharmaceuticals Rallying on Strong Outlook

    at Benzinga

  63. Jazz Pharmaceuticals Sees FY 2012 Adjusted EPS of $4.00 – 4.15 vs ...

    at Benzinga

  64. ETF Showdown: Fun With Pharma

    at Benzinga

  65. Best Biotech Stocks of 2011

    at Benzinga

  66. Jazz Pharmaceuticals (JAZZ) Hits 52-Week High of 44.45

    At Market Intelligence Center
People viewing JAZZ also viewed: , , , , , ,
Marketplace
Trading Center